Pattern of cardiac surveillance among patients with lymphoma receiving anthracycline-based chemotherapy

OBJECTIVE: Anthracyclines are potent antineoplastic agents in the treatment of lymphoid malignancies, but their therapeutic benefit is limited by cardiotoxicity. The American Heart Association (AHA) recommends routine surveillance, early diagnosis and treatment of anthracycline-based chemotherapy (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Olivia Y, Brown, Jennifer R, Dai, Tian, Easley, Kirk A, Flowers, Christopher R, Parashar, Susmita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606381/
https://www.ncbi.nlm.nih.gov/pubmed/26443656
http://dx.doi.org/10.1136/bmjopen-2015-008350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606381/
https://www.ncbi.nlm.nih.gov/pubmed/26443656
http://dx.doi.org/10.1136/bmjopen-2015-008350

Ejemplares similares